HSPA9 and hepatocellular carcinoma: Furthermore, Hillmer et al. reported that Sal-B specifically bound to mortalin and increased the degradation of mortalin proteasomes through ubiquitination, thereby upregulating RECK, inhibiting STAT3, and finally inhibiting the migration and invasion of HCC cells (Hillmer et al., 2016).